Altria Group Inc vs Smith & Nephew plc — how do they compare? Altria Group Inc trades at $73.25 (market cap $124.67B), while Smith & Nephew plc trades at $30.45 (market cap $12.64B). The key difference: Altria Group Inc is far larger — about 9.9× Smith & Nephew plc's market cap, and Altria Group Inc pays the higher dividend (5.68%). Which is the better fit depends on your goals.
| MO | SNN | |
|---|---|---|
Market Cap | $124.67B | $12.64B |
Sector | Consumer Staples | Health |
52-Week High | $74.66 | $38.70 |
52-Week Low | $54.72 | $28.73 |
Enterprise Value | $145.75B | $15.41B |
Dividend Yield | 5.68% | 2.57% |
Trailing returns across standard periods
Latest headlines on both assets
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →